Biomarker Summit 2012
San Diego, CA, USA (March, 15-16, 2012)
GTC is proud to present the Biomarker Summit 2012, to
be held March 15-16 in San Diego, California. Assembling leading
scientists, researchers, decision-makers and other players across the
industry spectrum, the Summit provides a unique opportunity to gain the
latest biomarker developments in diagnostics, oncology and the business
of biomarkers. The Summit's four tracks allows attendees to engage in
individual programs - or portions of all tracks - while enjoying
networking opportunities with all attendees, speakers, poster presenters
and exhibitors:
- 6th Biomarker Development Conference
- Biomarkers & Diagnostics Conference
- 4th Oncology Biomarker Conference
- Biomarker Partnering & Deal-Making Conference
This truly one-of-a-kind, single-stop event has
been carefully developed to provide insights into critical issues,
discoveries, developments and investments from the most respected names
within the biomarker industry.
The Summit features the following Conferences sessions:
Track 1: Biomarker Development Conference
Personalized Medicine for non-oncology uses (Dual Track)
Next Generation Sequencing and Discovery of New Diagnostics (Dual Track)
Biomarker Validation of Preclinical to Clinical Studies
Shortening Development times with Biomarker Defined Patient Populations
Biomarker s in Clinical Trials
Analytics in Biomarker Development
New Technologies & Novel Approaches in Biomarker Development
Track 2: Biomarker & Diagnostics Conference
Personalized Medicine for non-oncology uses (Dual Track)
Next Generation Sequencing and Discovery of New Diagnostics (Dual Track)
Statistical Analysis of New Potential Biomarkers
Patient Selection & Stratification in the Design of Clinical Trials for New Diagnostics
Novel Approaches & Emerging Technologies for Diagnostics
Circulating/Body Fluid Biomarkers Developments
Companion Diagnostics
Novel methods for Prediction Algorithms
Track 3: 4th Oncology Biomarkers Conference
Challenges to Clinical Translation of Oncology Biomarkers
Novel Approaches and Emerging Technologies of Oncology Biomarkers
Development of Targeted Oncology Biomarkers
Personalized Oncology Care
Advancements in Prognostic Markers
Biomarkers in Early Disease Diagnosis
Track 4: Partnering & Deal-Making Conference
Biomarker Investments in the Current Market (Featured Presentation)
Panel Discussion: Partnership & Investor Panel
Strategic Direction for Biomarker Partnering
Achieving IP on Biomarkers (Individual Presentation)
Panel Discussion: Diagnostic Reimbursements in a new Era
Novel Developments in Technology
Models and Trends in Partnering
Keynote Speaker: Steven J. Skates, Ph.D., Associate Professor of Medicine, Massachusetts General Hospital Cancer Center
Keynote Speaker: Prof. Dr. med. Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare
More: http://www.gtcbio.com/component/conference/?file=home&cn=Biomarker+Sum
